ACT

NOVEMBER 14/2017


Advertisment

news roundup

EFPIA Voices Fresh Concerns on EMA Relocation

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has provided further evidence of the potential health risks posed by the upcoming relocation of the EMA.


advertisment

ERT Video Series
Check out the ERT video series, filmed on the show floor at DIA 2017, for interviews on Innovating Clinical Trial Management, eCOA in Clinical Research: Trends and Advances, and Optimizing Clinical Trial Imaging through Advanced Technology.
Click here to watch all 10 short videos


In this edition

DIA Jumps on Brexit Bandwagon
The Risk Based Monitoring Plan
Overcoming the Challenges of Real-World Data Capture in Observational Studies
CRF Health Solution Selected for Large Oncology Study
advertisment

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »



Advertisment

Industry Survey Shows Changes on eClinical Horizon

The 2017 eClinical Landscape Study: Assessing Data Management Practices, Performance, and Challenges from the Tufts Center for the Study of Drug Development, reviews the state of data management in life sciences with an in-depth look at the insights and opinions of clinical data management professionals at more than 250 companies, including sponsors and CROs.


advertisment

Tomorrow's Clinical Trial, Powered by Modern EDC
See how to cut study build time in half, eliminate migrations, and remove the need for source data verification (SDV).
See a preview and watch the full webinar here.

advertisment
Advertisment

DIA Jumps on Brexit Bandwagon

The considerable uncertainty caused by Brexit is proving a goldmine for conference organizers, it seems. The Drug Information Association (DIA) is the latest group to put together a meeting about this hot topic.


advertisment

Navigating the Regulatory Complexities of Orphan Drugs: Know the unwritten rules of designations and what's next
On Demand
Learn more


Bioclinica Acquires MDDX Research & Informatics

Bioclinica announced it has acquired Silicon Valley-based MDDX Research & Informatics, adding advanced cloud research image management and submission technologies to its extensive suite of eHealth solutions.


advertisment

Future-proofing your Pharmacovigilance Delivery Model: Achieving scalability and cost effectiveness with AI/smart machines
On Demand
Learn more

advertisment

Beyond #Buzzwords: How to deploy wearables and remote devices to transform your clinical trial execution
Live Webinar: Tuesday, December 5 at 11:00 am EST
Register now


Events

Partnerships in Clinical Trials Europe
BioPharma Forum on Cannabis-Based Therapies
Clinical Trial Legal and Contracting Forum
eCOA/ePRO 2017
Search Upcoming Events

advertisment

Rare Diseases and the Eye - Envisioning Strategies for Success
On Demand
Learn more


Advertisment

Articles

The Risk Based Monitoring Plan

Sponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.


advertisment

RBM Technology Impact on Clinical Roles: Centralized Monitoring is streamlining activities and changing roles across clinical development
On Demand
Learn more


Four Pillars to Achieve Patient Centricity

ZS Associates specify the four pillars of patient centricity that can help the demands and complexities of clinical trials.

Blog Posts

How to Keep the EU Authorization System Running

The operational subject of how the centralized authorization procedure is going to work when the UK is no longer part of the European Union is being discussed.


Overcoming the Challenges of Real-World Data Capture in Observational Studies

In this three-part blog series, we look at how electronic platforms can support and enhance data capture in several types of RWD programs: observational studies, pragmatic trials, and commercial programs.


Oncology

Researchers Conduct NH Studies for Rare Disease and Drug Development

The use of Natural History studies in order to examine a rare disease that will help facilitate drug development programs.

 

CRF Health Solution Selected for Large Oncology Study

CRF Health announced that its TrialMax Touch® solution has been selected for a landmark global oncology trial. The trial will involve more than 1,000 patients across 200 sites in 20 countries.

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Mike Tessalone
Publisher
Michael.Tessalone@ubm.com